Amino.Desk

N-acetyl Selank amidate

Updated Nov 17, 2026 · Clinical review: pending

N-acetyl Selank amidate is Selank with a chemical cap on each end, added so the peptide resists breakdown. It is sold as a stronger anti-anxiety peptide. The modified version has not been studied in people.

What it is

Selank is a seven-amino-acid peptide developed in Russia from a natural immune peptide. This version adds an acetyl group at one end and an amide at the other to slow its breakdown.

What the evidence shows

The claims on seller pages, that the modified version is more potent, lasts longer and reaches the brain better, are not backed by a human study. A clinical education source notes that the existing evidence is about Selank as studied and registered, not about this molecule.

Selank's own human evidence is limited to small, mostly Russian studies, often run by the institutions that developed it.

Legal status

Reported dosing

We do not publish a protocol for this compound.

No dose has been established for this modified version. Dosing on seller pages is borrowed from the parent peptide or invented.

Safety

Common questions

Is N-acetyl Selank amidate stronger than Selank?

Sellers say so. No human study has tested it.

Has N-acetyl Selank amidate been studied in humans?

No. The human studies are of unmodified Selank.

Is it FDA-approved?

No.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy